Dissemination (Meeting Coverage)

Researchers conducted the MATCH study to assess the clinical benefits of adding low-dose...

According to IMpower133 and CASPIAN, anti-PD-L1 blockades combined with etoposide and platinum...

Researchers studied neoadjuvant immunotherapy to produce a pathologic response in patients with...

Merkel Cell Carcinoma (MCC) was rare, and aggressive skin cancer became more common as the...

Cancer’s biological behavior was exceedingly complex, driven by the nonlinear interplay of...

Cutaneous squamous cell carcinoma was the most frequent type of skin cancer globally. The presence...

In the United States, almost 1.5 million cutaneous squamous cell cancer (cSCC) are identified...

Researchers previously demonstrated improved efficacy of acalabrutinib (A) obinutuzumab (O) vs. O...

Acalabrutinib (Acala) was a next-generation, highly selective, covalent Bruton tyrosine kinase...

Over the last 2 decades, treatment for chronic lymphocytic leukemia (CLL) has evolved...

For a study, researchers sought to see if patients with chronic lymphocytic leukemia (CLL) who...

To analyze the link between cachexia and prognosis among patients with extensive-stage small-cell...

For a study, researchers sought to look at how patient characteristics and treatment patterns for...

Leukemia was the seventh most prevalent cause of mortality among cancer patients. It was...

During their hospitalization for rigorous chemotherapy, patients with Acute Myeloid Leukemia (AML)...

While the cause of multiple sclerosis (MS) was unknown, evidence showed that herpesviruses (HVs),...

Health professionals have urged studies to measure people’s “happiness” by...

Even though spasticity is prevalent, persons with multiple sclerosis (MS) with spasticity (PwMSS)...